Elevai Labs notes potential for hair restoration with exosome technology

Elevai Labs announced data results from an on-going research study conducted in partnership with Carly Klein, President of the National Hair Loss Medical Aesthetics NHLMA, demonstrating the potential of its proprietary Elevai Exosomes in hair restoration.The research study assessed the application of topical Elevai exosomes, in clinic and at home, on participants experiencing hair loss or hair thinning. Study participants were given in-office treatment consisting of scalp microneedling, then Elevai empower a topical exosome serum designed specifically for in-office application was applied, followed by at-home use of Elevai enfinity a topical exosome product, on the areas of concern. Results were assessed using imaging analysis up to 12 months, showing ceased crown inflammation, reversal of miniaturized hairs and recovered hair from the dormant phase, among other benefits. “We tested patients with androgenetic alopecia, delivering Elevai’s unique age zero exosomes to the scalp focusing on areas of thinning”, said Carly Klein, President of NHLMA. “These exosomes were utilized in the early and late stages of hair loss, and we saw promising results, giving us confidence that this technology can be used successfully in combination with other hair restoration approaches.”